Effects of an Early Invasive Strategy on Ischemia and Exercise Tolerance among Patients with Unstable Coronary Artery Disease

American Journal of Medicine

Volumn 115, Issue 8, 2003, Pages 606-612

  Diderholm, Erik ^a   Andrén, Bertil ^a   Frostfeldt, Gunnar ^a   Genberg, Margareta ^a   Jernberg, Tomas ^a   Lagerqvist, Bo ^a   Lindahl, Bertil ^a   Wallentin, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BICYCLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; METHODOLOGY; PATIENT; PRIORITY JOURNAL; RANDOMIZATION; ST SEGMENT DEPRESSION; SYMPTOM;

EID: 0345167958     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.06.003     Document Type: Article

References (24)

1. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994;89:1545-1556.
2. Boden W.E., O'Rourke R.A., Crawford M.H., et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 338:1998;1785-1792.
3. McCullough P.A., O'Neill W.W., Graham M., et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the Medicine versus Angiography in Thrombolytic Exclusion (MATE) trial. J Am Coll Cardiol. 32:1998;596-605.
4. Invasive compared with noninvasive treatment in unstable coronary-artery disease FRISC II prospective randomised multicentre study . Lancet. 354:1999;708-715.
5. Michalis L.K., Stroumbis C.S., Pappas K., et al. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS Study). Eur Heart J. 21:2000;1954-1959.
6. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.
7. Spacek R., Widimsky P., Straka Z., et al. Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction an open multicenter randomized trial. The VINO Study . Eur Heart J. 23:2002;230-238.
8. Fox K.A., Poole-Wilson P.A., Henderson R.A., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina . Lancet. 360:2002;743-751.
9. Wallentin L., Lagerqvist B., Husted S., et al. Outcome at 1 year after an invasive compared with a noninvasive strategy in unstable coronary-artery disease the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease . Lancet. 356:2000;9-16.
10. Long-term low-molecular-mass heparin in unstable coronary-artery disease FRISC II prospective randomised multicentre study . Lancet. 354:1999;701-707.
11. Borg G.A. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 14:1982;377-381.
12. Jette M., Sidney K., Blumchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol. 13:1990;555-565.
13. Nyman I., Wallentin L., Areskog M., et al. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group. Int J Cardiol. 39:1993;131-142.
14. Lindahl B., Andren B., Ohlsson J., et al. Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J. 18:1997;762-770.
15. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 335:1996;775-782.
16. Low-molecular-weight heparin during instability in coronary artery disease. Lancet. 347:1996;561-568.
17. Antman E.M., McCabe C.H., Gurfinkel E.P., et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) IIB trial. Circulation. 100:1999;1593-1601.
18. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 338:1998;1498-1505.
19. Hedback B.E., Perk J., Engvall J., Areskog N.H. Cardiac rehabilitation after coronary artery bypass grafting effects on exercise perfor-mance and risk factors . Arch Phys Med Rehabil. 71:1990;1069-1073.
20. Gohlke H., Gohlke-Barwolf C., Samek L., et al. Serial exercise testing up to 6 years after coronary bypass surgery behavior of exercise parameters in groups with different degrees of revascularization determined by postoperative angiography . Am J Cardiol. 51:1983;1301-1306.
21. Meier B., Gruentzig A.R., Siegenthaler W.E., Schlumpf M. Long-term exercise performance after percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. Circulation. 68:1983;796-802.
22. Sjoland H., Herlitz J., Karlson B.W., et al. Influence of patient sex and clinical history on working capacity and myocardial ischemia after coronary artery bypass surgery. Coron Artery Dis. 6:1995;561-571.
23. Ernst S.M., Hillebrand F.A., Klein B., et al. The value of exercise tests in the follow-up of patients who underwent transluminal coronary angioplasty. Int J Cardiol. 7:1985;267-279.
24. Wilcox I., Freedman S.B., Allman K.C., et al. Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol. 18:1991;677-683.